Ebola virus: A global public health frightening


  • Khitam F. Abbas
  • Layla Saleh Abdul-Hassan
  • Sama S. Abd Al_Ameer
  • Taghreed F. Almahbobi
  • Ameer S. Alkhayyat
  • Hujran Abdulraheem Abed
  • Oday Mitib Hadi
  • Baraa Akeel Al-Hasan
  • Maryam. R. Mansor
  • Estabraq Hassan Badder Al-Muhanna




Ebola virus disease; Ebola hemorrhagic fever; diagnosis; treatment.


Ebola virus causes disease, previously known as the hemorrhagic fever, is a menace routinely lethal sickness triggered by infection per the Filoviridae family's Ebola virus. The Ebola virus (EBOV) is feast by commerce by means of the blood or bodily fluids of someone who has contracted or died from EVD, as well as contaminated things like as needles, animals that was infected, otherwise bush meat. EVD takes two days to three weeks’ incubation period then an rushed inception devoid of the need for a carrier status. A flu-like syndrome is characterized by a rapid onset of high fever, chills, and myalgia, among other clinical signs. It's generally identified by a combination of clinical symptoms, including start of disease, high fevers lasting fewer than 3 weeks, and as a minimum 2 hemorrhagic symptoms in spite of no predisposing causes. This is usually enough evidence for physicians to suspect EHF and start supportive therapy until test findings confirm the virus. Patients first show with nonspecific influenza similar symptoms before succumbing to shock and several organ failures. severe bleeding problems and several organ failures are the leading causes of death. For the reason that there is presently not any conventional rehabilitation for EVD, this one is perilous to minimize contagion and the virus's transmission. Supportive treatment for patients includes maintaining fluid balance, electrolyte balance, hypertension, and oximetry, beside that treatment consequences arise after secondary infections. This review gives a comprehensive summary of the Ebola virus.







How to Cite

Ebola virus: A global public health frightening. (2022). Journal of Pharmaceutical Negative Results, 13(3), 766-768. https://doi.org/10.47750/pnr.2022.13.03.115